HK2 and cancer: In many types of cancers, c-Myc is always activated and plays key role in reprogramming glycolytic metabolism by activating its target genes, like GLUT1, HK2, PKM2 and LDHA, and then results in cancer cell proliferation, migration and metastasis [39, 40].